This is a Validated Antibody Database (VAD) review about human CES2, based on 4 published articles (read how Labome selects the articles), using CES2 antibody in all methods. It is aimed to help Labome visitors find the most suited CES2 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
CES2 synonym: CE-2; CES2A1; PCE-2; iCE; cocaine esterase; carboxylesterase 2 (intestine, liver); hCE-2; intestinal carboxylesterase; liver carboxylesterase-2; methylumbelliferyl-acetate deacetylase 2
Abcam
| rabbit polyclonal | Abcam CES2 antibody (Abcam, ab137606) was used . J Biol Chem (2017) ncbi | |
| rabbit monoclonal (EPR14856) |
| Abcam CES2 antibody (Abcam, ab184957) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig 5) and in western blot on human samples at 1:1000 (fig 6a). Oncotarget (2016) ncbi |
Santa Cruz Biotechnology
| mouse monoclonal (G5) |
| Santa Cruz Biotechnology CES2 antibody (Santa Cruz Biotechnology, Sc-100685) was used in western blot on human samples at 1:250 (fig 3). Oncotarget (2016) ncbi |
MilliporeSigma
| rabbit polyclonal |
| In order to characterize the functional and prognostic importance of MAP4K5 in pancreatic cancer, MilliporeSigma CES2 antibody (Sigma, HPA018897) was used in immunohistochemistry - paraffin section on human samples at 1:1000 (tbl 2). PLoS ONE (2016) ncbi |
Articles Reviewed
- Verbrugge S, Al M, Assaraf Y, Kammerer S, Chandrupatla D, Honeywell R, et al. Multifactorial resistance to aminopeptidase inhibitor prodrug CHR2863 in myeloid leukemia cells: down-regulation of carboxylesterase 1, drug sequestration in lipid droplets and pro-survival activation ERK/Akt/mTOR. Oncotarget. 2016;7:5240-57 pubmed publisher
contribute
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.
questions and comments
